Modulated release of cyclosporine from soluble vinyl pyrrolidone–hydroxyethyl methacrylate copolymer hydrogels: A correlation of ‘in vitro’ and ‘in vivo’ experiments

Soluble, uncrosslinked and high molecular weight copolymers of vinylpyrrolidone, VP, with 2-hydroxyethyl methacrylate, HEMA, prepared by free radical copolymerization, are proposed as supports for the modulated release of the immunosuppressor cyclosporine. Two copolymeric systems with copolymer comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2001-05, Vol.72 (1), p.1-11
Hauptverfasser: Gallardo, Alberto, Fernández, Fernando, Cifuentes, Alejandro, Dı́ez-Masa, José-Carlos, Bermejo, Paloma, Rebuelta, Mercedes, López-Bravo, Antonio, San Román, Julio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue 1
container_start_page 1
container_title Journal of controlled release
container_volume 72
creator Gallardo, Alberto
Fernández, Fernando
Cifuentes, Alejandro
Dı́ez-Masa, José-Carlos
Bermejo, Paloma
Rebuelta, Mercedes
López-Bravo, Antonio
San Román, Julio
description Soluble, uncrosslinked and high molecular weight copolymers of vinylpyrrolidone, VP, with 2-hydroxyethyl methacrylate, HEMA, prepared by free radical copolymerization, are proposed as supports for the modulated release of the immunosuppressor cyclosporine. Two copolymeric systems with copolymer compositions f VP=0.52 (namely VP–HEMA 60–40) and 0.42 (VP–HEMA 40–60) have been prepared and tested in vitro and in vivo using rats as animal model. Micellar electrokinetic capillary chromatography, MEKC, has been used for the simultaneous detection of the polymer reabsorption and the drug release for the in vitro experiments. The composition and microstructural distribution of the copolymer system controls the solubilization rate which modulates the in vitro release of the drug (with time profiles from a few days to several weeks for the VP–HEMA 60–40 and 40–60, respectively) and the in vivo response that correlates with the previous in vitro results: the more hydrophobic implant (VP–HEMA 40–60) reverts the immune response more slowly (2–4 weeks) compared to the more hydrophilic one (VP–HEMA 60–40, 1–2 weeks).
doi_str_mv 10.1016/S0168-3659(01)00257-7
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_17903961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365901002577</els_id><sourcerecordid>17903961</sourcerecordid><originalsourceid>FETCH-LOGICAL-e323t-54abfbbfd734dae2f71d5fbe2e3aa206063056cef3a5fa84fb05236b95d9ec753</originalsourceid><addsrcrecordid>eNpFkU1uFDEQhS1ERIbAEUBeIASLBrvd7p9sUBRBQApiAawtt10mRm67sbtH6d3cgQ05BXeak8QzGcKmSnr16VWpHkLPKHlDCa3ffs2lLVjNu1eEviak5E3RPEAr2jasqLqOP0Sre-QYPU7pJyGEs6p5hI4pZW3XtWSF_n4OenZyAo0jOJAJcDBYLcqFNIZoPWATw4BTcHPvAK-tXxwelxiDszp42G5-Xy06husFpqs8GnKTKi47T6zCGNwyQMR75ge4dIrPshzzMjnZ4Hfbtps_1mfnKYbt5gZLr--l9V6B6xGiHcBP6Qk6MtIleHroJ-j7h_ffzj8Wl18uPp2fXRbASjYVvJK96XujG1ZpCaVpqOamhxKYlCWpSc0IrxUYJrmRbWV6wktW9x3XHaiGsxP08s53jOHXDGkSg00KnJMewpwEbTrCuppm8PkBnPsBtBjzoTIu4t-LM_DiAMikpDNRemXTf45UrC5Zxt7dYflHsLYQRVIWvAJtI6hJ6GAzK3bZi332YhesIFTssxcNuwUNjqr8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17903961</pqid></control><display><type>article</type><title>Modulated release of cyclosporine from soluble vinyl pyrrolidone–hydroxyethyl methacrylate copolymer hydrogels: A correlation of ‘in vitro’ and ‘in vivo’ experiments</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gallardo, Alberto ; Fernández, Fernando ; Cifuentes, Alejandro ; Dı́ez-Masa, José-Carlos ; Bermejo, Paloma ; Rebuelta, Mercedes ; López-Bravo, Antonio ; San Román, Julio</creator><creatorcontrib>Gallardo, Alberto ; Fernández, Fernando ; Cifuentes, Alejandro ; Dı́ez-Masa, José-Carlos ; Bermejo, Paloma ; Rebuelta, Mercedes ; López-Bravo, Antonio ; San Román, Julio</creatorcontrib><description>Soluble, uncrosslinked and high molecular weight copolymers of vinylpyrrolidone, VP, with 2-hydroxyethyl methacrylate, HEMA, prepared by free radical copolymerization, are proposed as supports for the modulated release of the immunosuppressor cyclosporine. Two copolymeric systems with copolymer compositions f VP=0.52 (namely VP–HEMA 60–40) and 0.42 (VP–HEMA 40–60) have been prepared and tested in vitro and in vivo using rats as animal model. Micellar electrokinetic capillary chromatography, MEKC, has been used for the simultaneous detection of the polymer reabsorption and the drug release for the in vitro experiments. The composition and microstructural distribution of the copolymer system controls the solubilization rate which modulates the in vitro release of the drug (with time profiles from a few days to several weeks for the VP–HEMA 60–40 and 40–60, respectively) and the in vivo response that correlates with the previous in vitro results: the more hydrophobic implant (VP–HEMA 40–60) reverts the immune response more slowly (2–4 weeks) compared to the more hydrophilic one (VP–HEMA 60–40, 1–2 weeks).</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/S0168-3659(01)00257-7</identifier><identifier>PMID: 11389980</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>2-Hydroxyethyl methacrylate ; Animals ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Copolymers ; cyclosporin A ; Cyclosporine ; Cyclosporine - administration &amp; dosage ; Cyclosporine - adverse effects ; Cyclosporine - pharmacokinetics ; Drug Carriers - chemistry ; Drug Compounding ; Drug Implants ; General pharmacology ; hydrogels ; Hydrogels - chemistry ; hydroxyethyl methacrylate ; Immunosuppressive Agents - administration &amp; dosage ; Immunosuppressive Agents - pharmacokinetics ; Male ; Medical sciences ; Methacrylates - chemistry ; Muscle, Skeletal - pathology ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Povidone - chemistry ; Rats ; Rats, Wistar ; Solubility ; vinyl pyrrolidone ; Vinylpyrrolidone</subject><ispartof>Journal of controlled release, 2001-05, Vol.72 (1), p.1-11</ispartof><rights>2001 Elsevier Science B.V.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0168-3659(01)00257-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1043623$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11389980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gallardo, Alberto</creatorcontrib><creatorcontrib>Fernández, Fernando</creatorcontrib><creatorcontrib>Cifuentes, Alejandro</creatorcontrib><creatorcontrib>Dı́ez-Masa, José-Carlos</creatorcontrib><creatorcontrib>Bermejo, Paloma</creatorcontrib><creatorcontrib>Rebuelta, Mercedes</creatorcontrib><creatorcontrib>López-Bravo, Antonio</creatorcontrib><creatorcontrib>San Román, Julio</creatorcontrib><title>Modulated release of cyclosporine from soluble vinyl pyrrolidone–hydroxyethyl methacrylate copolymer hydrogels: A correlation of ‘in vitro’ and ‘in vivo’ experiments</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Soluble, uncrosslinked and high molecular weight copolymers of vinylpyrrolidone, VP, with 2-hydroxyethyl methacrylate, HEMA, prepared by free radical copolymerization, are proposed as supports for the modulated release of the immunosuppressor cyclosporine. Two copolymeric systems with copolymer compositions f VP=0.52 (namely VP–HEMA 60–40) and 0.42 (VP–HEMA 40–60) have been prepared and tested in vitro and in vivo using rats as animal model. Micellar electrokinetic capillary chromatography, MEKC, has been used for the simultaneous detection of the polymer reabsorption and the drug release for the in vitro experiments. The composition and microstructural distribution of the copolymer system controls the solubilization rate which modulates the in vitro release of the drug (with time profiles from a few days to several weeks for the VP–HEMA 60–40 and 40–60, respectively) and the in vivo response that correlates with the previous in vitro results: the more hydrophobic implant (VP–HEMA 40–60) reverts the immune response more slowly (2–4 weeks) compared to the more hydrophilic one (VP–HEMA 60–40, 1–2 weeks).</description><subject>2-Hydroxyethyl methacrylate</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Copolymers</subject><subject>cyclosporin A</subject><subject>Cyclosporine</subject><subject>Cyclosporine - administration &amp; dosage</subject><subject>Cyclosporine - adverse effects</subject><subject>Cyclosporine - pharmacokinetics</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Compounding</subject><subject>Drug Implants</subject><subject>General pharmacology</subject><subject>hydrogels</subject><subject>Hydrogels - chemistry</subject><subject>hydroxyethyl methacrylate</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Immunosuppressive Agents - pharmacokinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methacrylates - chemistry</subject><subject>Muscle, Skeletal - pathology</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Povidone - chemistry</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Solubility</subject><subject>vinyl pyrrolidone</subject><subject>Vinylpyrrolidone</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1uFDEQhS1ERIbAEUBeIASLBrvd7p9sUBRBQApiAawtt10mRm67sbtH6d3cgQ05BXeak8QzGcKmSnr16VWpHkLPKHlDCa3ffs2lLVjNu1eEviak5E3RPEAr2jasqLqOP0Sre-QYPU7pJyGEs6p5hI4pZW3XtWSF_n4OenZyAo0jOJAJcDBYLcqFNIZoPWATw4BTcHPvAK-tXxwelxiDszp42G5-Xy06husFpqs8GnKTKi47T6zCGNwyQMR75ge4dIrPshzzMjnZ4Hfbtps_1mfnKYbt5gZLr--l9V6B6xGiHcBP6Qk6MtIleHroJ-j7h_ffzj8Wl18uPp2fXRbASjYVvJK96XujG1ZpCaVpqOamhxKYlCWpSc0IrxUYJrmRbWV6wktW9x3XHaiGsxP08s53jOHXDGkSg00KnJMewpwEbTrCuppm8PkBnPsBtBjzoTIu4t-LM_DiAMikpDNRemXTf45UrC5Zxt7dYflHsLYQRVIWvAJtI6hJ6GAzK3bZi332YhesIFTssxcNuwUNjqr8</recordid><startdate>20010514</startdate><enddate>20010514</enddate><creator>Gallardo, Alberto</creator><creator>Fernández, Fernando</creator><creator>Cifuentes, Alejandro</creator><creator>Dı́ez-Masa, José-Carlos</creator><creator>Bermejo, Paloma</creator><creator>Rebuelta, Mercedes</creator><creator>López-Bravo, Antonio</creator><creator>San Román, Julio</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20010514</creationdate><title>Modulated release of cyclosporine from soluble vinyl pyrrolidone–hydroxyethyl methacrylate copolymer hydrogels: A correlation of ‘in vitro’ and ‘in vivo’ experiments</title><author>Gallardo, Alberto ; Fernández, Fernando ; Cifuentes, Alejandro ; Dı́ez-Masa, José-Carlos ; Bermejo, Paloma ; Rebuelta, Mercedes ; López-Bravo, Antonio ; San Román, Julio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e323t-54abfbbfd734dae2f71d5fbe2e3aa206063056cef3a5fa84fb05236b95d9ec753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>2-Hydroxyethyl methacrylate</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Copolymers</topic><topic>cyclosporin A</topic><topic>Cyclosporine</topic><topic>Cyclosporine - administration &amp; dosage</topic><topic>Cyclosporine - adverse effects</topic><topic>Cyclosporine - pharmacokinetics</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Compounding</topic><topic>Drug Implants</topic><topic>General pharmacology</topic><topic>hydrogels</topic><topic>Hydrogels - chemistry</topic><topic>hydroxyethyl methacrylate</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Immunosuppressive Agents - pharmacokinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methacrylates - chemistry</topic><topic>Muscle, Skeletal - pathology</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Povidone - chemistry</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Solubility</topic><topic>vinyl pyrrolidone</topic><topic>Vinylpyrrolidone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallardo, Alberto</creatorcontrib><creatorcontrib>Fernández, Fernando</creatorcontrib><creatorcontrib>Cifuentes, Alejandro</creatorcontrib><creatorcontrib>Dı́ez-Masa, José-Carlos</creatorcontrib><creatorcontrib>Bermejo, Paloma</creatorcontrib><creatorcontrib>Rebuelta, Mercedes</creatorcontrib><creatorcontrib>López-Bravo, Antonio</creatorcontrib><creatorcontrib>San Román, Julio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallardo, Alberto</au><au>Fernández, Fernando</au><au>Cifuentes, Alejandro</au><au>Dı́ez-Masa, José-Carlos</au><au>Bermejo, Paloma</au><au>Rebuelta, Mercedes</au><au>López-Bravo, Antonio</au><au>San Román, Julio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulated release of cyclosporine from soluble vinyl pyrrolidone–hydroxyethyl methacrylate copolymer hydrogels: A correlation of ‘in vitro’ and ‘in vivo’ experiments</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2001-05-14</date><risdate>2001</risdate><volume>72</volume><issue>1</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>Soluble, uncrosslinked and high molecular weight copolymers of vinylpyrrolidone, VP, with 2-hydroxyethyl methacrylate, HEMA, prepared by free radical copolymerization, are proposed as supports for the modulated release of the immunosuppressor cyclosporine. Two copolymeric systems with copolymer compositions f VP=0.52 (namely VP–HEMA 60–40) and 0.42 (VP–HEMA 40–60) have been prepared and tested in vitro and in vivo using rats as animal model. Micellar electrokinetic capillary chromatography, MEKC, has been used for the simultaneous detection of the polymer reabsorption and the drug release for the in vitro experiments. The composition and microstructural distribution of the copolymer system controls the solubilization rate which modulates the in vitro release of the drug (with time profiles from a few days to several weeks for the VP–HEMA 60–40 and 40–60, respectively) and the in vivo response that correlates with the previous in vitro results: the more hydrophobic implant (VP–HEMA 40–60) reverts the immune response more slowly (2–4 weeks) compared to the more hydrophilic one (VP–HEMA 60–40, 1–2 weeks).</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11389980</pmid><doi>10.1016/S0168-3659(01)00257-7</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2001-05, Vol.72 (1), p.1-11
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_17903961
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 2-Hydroxyethyl methacrylate
Animals
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Copolymers
cyclosporin A
Cyclosporine
Cyclosporine - administration & dosage
Cyclosporine - adverse effects
Cyclosporine - pharmacokinetics
Drug Carriers - chemistry
Drug Compounding
Drug Implants
General pharmacology
hydrogels
Hydrogels - chemistry
hydroxyethyl methacrylate
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - pharmacokinetics
Male
Medical sciences
Methacrylates - chemistry
Muscle, Skeletal - pathology
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Povidone - chemistry
Rats
Rats, Wistar
Solubility
vinyl pyrrolidone
Vinylpyrrolidone
title Modulated release of cyclosporine from soluble vinyl pyrrolidone–hydroxyethyl methacrylate copolymer hydrogels: A correlation of ‘in vitro’ and ‘in vivo’ experiments
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulated%20release%20of%20cyclosporine%20from%20soluble%20vinyl%20pyrrolidone%E2%80%93hydroxyethyl%20methacrylate%20copolymer%20hydrogels:%20A%20correlation%20of%20%E2%80%98in%20vitro%E2%80%99%20and%20%E2%80%98in%20vivo%E2%80%99%20experiments&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Gallardo,%20Alberto&rft.date=2001-05-14&rft.volume=72&rft.issue=1&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/S0168-3659(01)00257-7&rft_dat=%3Cproquest_pubme%3E17903961%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17903961&rft_id=info:pmid/11389980&rft_els_id=S0168365901002577&rfr_iscdi=true